Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
19.91B | 26.46B | 23.74B | 14.74B | 12.25B |
Gross Profit | ||||
4.09B | 9.62B | 2.04B | 1.63B | 3.12B |
EBIT | ||||
1.70B | 6.51B | -240.00M | 954.00M | -362.00M |
EBITDA | ||||
2.42B | 7.30B | 506.00M | 1.73B | 1.87B |
Net Income Common Stockholders | ||||
1.33B | 3.93B | -782.00M | 1.21B | 41.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
6.22B | 6.74B | 4.29B | 4.63B | 1.67B |
Total Assets | ||||
18.73B | 21.37B | 29.04B | 27.09B | 17.12B |
Total Debt | ||||
3.51B | 4.10B | 4.02B | 4.64B | 5.38B |
Net Debt | ||||
-2.71B | -2.24B | -270.00M | 18.00M | 3.70B |
Total Liabilities | ||||
13.92B | 17.13B | 27.76B | 24.34B | 15.74B |
Stockholders Equity | ||||
4.42B | 3.88B | 1.02B | 2.37B | 957.00M |
Cash Flow | Free Cash Flow | |||
733.00M | 2.42B | 943.00M | 1.19B | 911.00M |
Operating Cash Flow | ||||
1.15B | 2.75B | 1.31B | 1.61B | 1.40B |
Investing Cash Flow | ||||
493.00M | 115.00M | -566.00M | 2.26B | -285.00M |
Financing Cash Flow | ||||
-1.55B | -1.41B | -917.00M | -938.00M | -482.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $10.46B | 6.48 | 32.15% | 2.42% | -22.53% | -62.36% | |
73 Outperform | $49.25B | 20.01 | 46.29% | 0.63% | 49.22% | 313.49% | |
70 Outperform | $11.16B | 18.66 | 9.08% | 3.86% | 10.69% | 12.37% | |
64 Neutral | $9.11B | 18.72 | 10.72% | 3.79% | 15.56% | 21.90% | |
63 Neutral | $8.48B | 10.79 | 5.35% | 4.36% | 3.55% | -11.17% | |
63 Neutral | $11.80B | 4.72 | 9.32% | 0.51% | 2.37% | ― | |
62 Neutral | $23.83B | 23.29 | 41.79% | 1.38% | -1.72% | ― |